会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • METHOD FOR MEASURING CYSTATIN C IN HUMAN BODY FLUID
    • 测定人体液中胱氨酸C的方法
    • WO2010064435A8
    • 2010-09-16
    • PCT/JP2009006590
    • 2009-12-03
    • SEKISUI MEDICAL CO LTDNAKAYAMA SHINYATAKAHASHI HIROSHINAKAMURA YASUSHISHIMIZU TOMO
    • NAKAYAMA SHINYATAKAHASHI HIROSHINAKAMURA YASUSHISHIMIZU TOMO
    • G01N33/53G01N33/543G01N33/577
    • G01N33/543G01N33/6893G01N2333/8139
    • Disclosed is a particle-enhanced immunoassay method for cystatin C in a human body fluid, which has higher specificity, is more inexpensive, and can be automated more readily compared with conventional assay methods in which polyclonal antibodies having low specificity or monoclonal antibodies having high specificity but having poor aggregability have been used in large quantities. The particle-enhanced immunoassay method utilizes a combination of an antibody-sensitized particle comprising an insoluble carrier particle and an anti-human cystatin C monoclonal antibody having higher affinity and bound to the particle and an antibody-sensitized particle comprising the insoluble carrier particle and an anti-human cystatin C monoclonal antibody having a different recognition site from that of the aforementioned monoclonal antibody and having a relatively lower affinity, wherein the quantity of each of the human cystatin C monoclonal antibodies bound to the insoluble carrier particle is less than 5 wt% relative to the weight of the antibody-sensitized particle.
    • 公开了一种人体液中半胱氨酸蛋白酶抑制剂C的颗粒增强免疫测定方法,与特异性低的多克隆抗体或特异性高的单克隆抗体的常规测定方法相比,该方法具有更高的特异性,更便宜,并且可以更容易自动化 但具有较差的可聚合性已被大量使用。 颗粒增强免疫测定方法利用包含不溶性载体颗粒的抗体敏化颗粒和具有较高亲和力且结合于颗粒的抗人半胱氨酸蛋白酶抑制剂C单克隆抗体的组合以及包含不溶性载体颗粒和抗体敏化颗粒 与上述单克隆抗体具有不同识别位点并具有相对较低亲和力的抗人半胱氨酸蛋白酶抑制剂C单克隆抗体,其中与不溶性载体颗粒结合的每种人半胱氨酸蛋白酶抑制剂C单克隆抗体的量小于5重量% 相对于抗体致敏颗粒的重量。